Thomas Lenhard

Title: Thomas Lenhard: Innovator in Microfluidics and Protease Variants

Introduction

Thomas Lenhard is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the fields of microfluidics and pharmaceutical applications through his innovative patents. With a total of two patents to his name, Lenhard's work focuses on enhancing the performance of microbial host cells and protease variants.

Latest Patents

Lenhard's latest patents include a microfluidic device screening method and novel protease variants for pharmaceutical use. The microfluidic device screening method provides a systematic approach to screening microbial host cells for specific properties. This method involves transforming a d-alanine racemase-deficient microbial host cell with a polynucleotide construct that enhances the desired property while addressing the deficiency. The second patent relates to protease variants derived from specific strains, which show improved efficacy in treating pancreatic exocrine insufficiency and other digestive disorders. These variants can be combined with lipases and amylases for enhanced therapeutic effects.

Career Highlights

Throughout his career, Thomas Lenhard has worked with prominent companies such as Novozymes A/S and Solvay Pharmaceuticals GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology and pharmaceuticals.

Collaborations

Lenhard has collaborated with notable colleagues, including Mads E. Bjoernvad and Poul Erik Pedersen. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Thomas Lenhard's contributions to the fields of microfluidics and protease variants demonstrate his commitment to innovation and improvement in medical applications. His patents reflect a deep understanding of microbial processes and their potential for pharmaceutical advancements.